139 related articles for article (PubMed ID: 25811037)
1. Practice gaps and barriers to optimal care of hematologic malignancies in the United States.
Murray S; Obholz KL; Bowser AD; Mortimer J; Lazure P; Peterson E; Armitage JO; Smith BD
J Community Support Oncol; 2014 Sep; 12(9):329-338. PubMed ID: 25811037
[TBL] [Abstract][Full Text] [Related]
2. Practice challenges affecting optimal care as identifed by US medical oncologists who treat renal cell carcinomas.
Hayes SM; Bowser AD; Mortimer J; Lazure P; Peterson E; Hutson TE; Rini B
J Community Support Oncol; 2014 Jun; 12(6):197-204. PubMed ID: 24999496
[TBL] [Abstract][Full Text] [Related]
3. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of chronic myeloid leukemia: a survey of American and European practice patterns.
Kantarjian HM; Cortes J; Guilhot F; Hochhaus A; Baccarani M; Lokey L
Cancer; 2007 Apr; 109(7):1365-75. PubMed ID: 17326047
[TBL] [Abstract][Full Text] [Related]
5. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Identifying Educational Needs and Practice Gaps of European Hematologists and Hematology Nurses in the Treatment and Management of Multiple Myeloma.
Murray S; Mohty M; Peloquin S; Van de Donk NW; Leitão S; Labbé S; West S; Hofstädter-Thalmann E; Sonneveld P
Hemasphere; 2018; 2(2):e33. PubMed ID: 31723761
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
9. Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.
Wilson R; Godfrey CM; Sears K; Medves J; Ross-White A; Lambert N
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):146-55. PubMed ID: 26571290
[TBL] [Abstract][Full Text] [Related]
10. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics and clinical outcome of T315I mutation in Philadelphia chromosome-positive acute lymphoblastic leukemia and chronic myeloid leukemia].
Wang J; Zhang Y; Zu Y; Li Z; Li M; Song Y
Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):110-4. PubMed ID: 27014979
[TBL] [Abstract][Full Text] [Related]
12. Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists' experiences and perspectives.
van Lieshout R; Tick LW; de Beer F; Koene HR; Regelink JC; Westerweel PE; de Witte MA; Beckers EAM; Schouten HC; Beijer S
Clin Nutr ESPEN; 2023 Oct; 57():399-409. PubMed ID: 37739686
[TBL] [Abstract][Full Text] [Related]
13. Ponatinib: A new tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shamroe CL; Comeau JM
Ann Pharmacother; 2013 Nov; 47(11):1540-6. PubMed ID: 24265264
[TBL] [Abstract][Full Text] [Related]
14. A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Seymour JF; Kim DW; Rubin E; Haregewoin A; Clark J; Watson P; Hughes T; Dufva I; Jimenez JL; Mahon FX; Rousselot P; Cortes J; Martinelli G; Papayannidis C; Nagler A; Giles FJ
Blood Cancer J; 2014 Aug; 4(8):e238. PubMed ID: 25127392
[TBL] [Abstract][Full Text] [Related]
15. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
[TBL] [Abstract][Full Text] [Related]
16. Ponatinib in refractory Philadelphia chromosome-positive leukemias.
Cortes JE; Kantarjian H; Shah NP; Bixby D; Mauro MJ; Flinn I; O'Hare T; Hu S; Narasimhan NI; Rivera VM; Clackson T; Turner CD; Haluska FG; Druker BJ; Deininger MW; Talpaz M
N Engl J Med; 2012 Nov; 367(22):2075-88. PubMed ID: 23190221
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based medicine Training: Kazakhstan experience.
Kamalbekova G; Kalieva M
Int J Risk Saf Med; 2015; 27 Suppl 1():S95-6. PubMed ID: 26639732
[TBL] [Abstract][Full Text] [Related]
18. Challenges associated with the integration of immuno-oncology agents in clinical practice.
Lazure P; Parikh AR; Ready NE; Davies MJ; Péloquin S; Caterino JM; Lewandowski R; Lazar AJ; Murray S
BMC Med Educ; 2022 Nov; 22(1):781. PubMed ID: 36371179
[TBL] [Abstract][Full Text] [Related]
19. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model.
McCormick D; Bhatt DL; Bays HE; Taub PR; Caldwell KA; Guerin CK; Steinhoff J; Ahmad Z; Singh R; Moreo K; Carter J; Heggen CL; Sapir T
J Manag Care Spec Pharm; 2020 Dec; 26(12):1517-1528. PubMed ID: 33251993
[No Abstract] [Full Text] [Related]
20. Targeted chronic myeloid leukemia therapy: seeking a cure.
Fausel C
J Manag Care Pharm; 2007 Oct; 13(8 Suppl A):8-12. PubMed ID: 17970609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
